Progress of surgery-prioritized comprehensive therapy for adenocarcinoma of esophagogastric junction

VernacularTitle:以手术为主的食管胃交界部腺癌综合治疗研究进展
Author: Guochao ZHANG ¹ ; Gefei ZHAO
Author Information

1. 100021,国家癌症中心/中国医学科学院北京协和医学院肿瘤医院胸外科
Keywords: Esophageal neoplasms; Stomach neoplasms; Adenocarcinoma; Surgical procedures,operative; Combined modality therapy; Neoadjuvant therapy
From: Cancer Research and Clinic 2017;29(11):788-792
CountryChina
Language:Chinese
Abstract: The classification and treatment patterns of adenocarcinoma of esophagogastric junction (AEG)do not comply with the"gold standard"for its unique anatomical location and biological characteristics. With an increasing incidence rate of AEG in recent years, the importance of AEG in public health has caught much attention. Surgery is considered as the first choice for the treatment of AEG, but surgical treatments for different types of AEG is still controversial. Many clinical trials have proved the adjuvant therapy and neoadjuvant therapy are beneficial to the improvement of surgical resection and survival rate. Molecular targeted drugs might bring light for the treatment of advanced AEG. Individual therapy of AEG has become increasingly important with the development of science and technology and the results of large clinical researches published. This article reviews the latest progress of surgery-prioritized multimodality therapy for AEG.